Combined therapy can reduce chance of recurrence in women with small, HER2+ breast tumors

(Dana-Farber Cancer Institute) Dana-Farber researchers report women with small, HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted drug following surgery were highly unlikely to have the cancer recur within three years.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news